EPCT-02. COMPARISON OF TARGETED AGENTS RECOMMENDED BY THE CNS-TAP TOOL TO THOSE SELECTED BY A TUMOR BOARD IN A MOLECULARLY-DRIVEN DIPG CLINICAL TRIAL

Recently, sequencing of diffuse intrinsic pontine glioma (DIPG) biopsy specimens has revealed genomic heterogeneity of these tumors, fueling an interest in individualized, targeted treatment options. The Pacific Pediatric Neuro-Oncology Consortium recently completed enrollment onto a feasibility stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Holly, Ravi, Karthik, Marini, Bernard, Kline, Cassie, Mueller, Sabine, Koschmann, Carl, Franson, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Translational/Early Phase Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168218/
http://dx.doi.org/10.1093/neuonc/noab090.188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168218/
http://dx.doi.org/10.1093/neuonc/noab090.188

Ejemplares similares